You have free access to this content

Alimentary Pharmacology & Therapeutics

Cover image for Vol. 36 Issue 1

July 2012

Volume 36, Issue 1

Pages 1–78

  1. EDITORS' DECLARATIONS OF INTEREST

    1. Top of page
    2. EDITORS' DECLARATIONS OF INTEREST
    3. REVIEW ARTICLE
    4. EPSTEIN-BARR HEPATITIS
    5. NON-ALCOHOLIC FATTY LIVER DISEASE
    6. UPPER GI HAEMORRHAGE MORTALITY
    7. PEPTIC ULCER DISEASE
    8. PREGNANCY AND IBD
    9. SECRETORY DIARRHOEA
    10. INVITED COMMENTARIES
    11. LETTERS TO THE EDITORS
    1. You have free access to this content
      Editors' declarations of interest (pages 1–2)

      Version of Record online: 1 JUN 2012 | DOI: 10.1111/j.1365-2036.2012.05172.x

  2. REVIEW ARTICLE

    1. Top of page
    2. EDITORS' DECLARATIONS OF INTEREST
    3. REVIEW ARTICLE
    4. EPSTEIN-BARR HEPATITIS
    5. NON-ALCOHOLIC FATTY LIVER DISEASE
    6. UPPER GI HAEMORRHAGE MORTALITY
    7. PEPTIC ULCER DISEASE
    8. PREGNANCY AND IBD
    9. SECRETORY DIARRHOEA
    10. INVITED COMMENTARIES
    11. LETTERS TO THE EDITORS
    1. You have free access to this content
      Review article: current treatment options and management of functional dyspepsia (pages 3–15)

      B. E. Lacy, N. J. Talley, G. R. Locke III, E. P. Bouras, J. K. DiBaise, H. B. El-Serag, B. P. Abraham, C. W. Howden, P. Moayyedi and C. Prather

      Version of Record online: 16 MAY 2012 | DOI: 10.1111/j.1365-2036.2012.05128.x

  3. EPSTEIN-BARR HEPATITIS

    1. Top of page
    2. EDITORS' DECLARATIONS OF INTEREST
    3. REVIEW ARTICLE
    4. EPSTEIN-BARR HEPATITIS
    5. NON-ALCOHOLIC FATTY LIVER DISEASE
    6. UPPER GI HAEMORRHAGE MORTALITY
    7. PEPTIC ULCER DISEASE
    8. PREGNANCY AND IBD
    9. SECRETORY DIARRHOEA
    10. INVITED COMMENTARIES
    11. LETTERS TO THE EDITORS
    1. You have free access to this content
      Characteristics of Epstein–Barr virus hepatitis among patients with jaundice or acute hepatitis (pages 16–21)

      L. J. Vine, K. Shepherd, J. G. Hunter, R. Madden, C. Thornton, V. Ellis, R. P. Bendall and H. R. Dalton

      Version of Record online: 3 MAY 2012 | DOI: 10.1111/j.1365-2036.2012.05122.x

  4. NON-ALCOHOLIC FATTY LIVER DISEASE

    1. Top of page
    2. EDITORS' DECLARATIONS OF INTEREST
    3. REVIEW ARTICLE
    4. EPSTEIN-BARR HEPATITIS
    5. NON-ALCOHOLIC FATTY LIVER DISEASE
    6. UPPER GI HAEMORRHAGE MORTALITY
    7. PEPTIC ULCER DISEASE
    8. PREGNANCY AND IBD
    9. SECRETORY DIARRHOEA
    10. INVITED COMMENTARIES
    11. LETTERS TO THE EDITORS
    1. You have free access to this content
  5. UPPER GI HAEMORRHAGE MORTALITY

    1. Top of page
    2. EDITORS' DECLARATIONS OF INTEREST
    3. REVIEW ARTICLE
    4. EPSTEIN-BARR HEPATITIS
    5. NON-ALCOHOLIC FATTY LIVER DISEASE
    6. UPPER GI HAEMORRHAGE MORTALITY
    7. PEPTIC ULCER DISEASE
    8. PREGNANCY AND IBD
    9. SECRETORY DIARRHOEA
    10. INVITED COMMENTARIES
    11. LETTERS TO THE EDITORS
    1. You have free access to this content
  6. PEPTIC ULCER DISEASE

    1. Top of page
    2. EDITORS' DECLARATIONS OF INTEREST
    3. REVIEW ARTICLE
    4. EPSTEIN-BARR HEPATITIS
    5. NON-ALCOHOLIC FATTY LIVER DISEASE
    6. UPPER GI HAEMORRHAGE MORTALITY
    7. PEPTIC ULCER DISEASE
    8. PREGNANCY AND IBD
    9. SECRETORY DIARRHOEA
    10. INVITED COMMENTARIES
    11. LETTERS TO THE EDITORS
    1. You have free access to this content
    2. You have free access to this content
  7. PREGNANCY AND IBD

    1. Top of page
    2. EDITORS' DECLARATIONS OF INTEREST
    3. REVIEW ARTICLE
    4. EPSTEIN-BARR HEPATITIS
    5. NON-ALCOHOLIC FATTY LIVER DISEASE
    6. UPPER GI HAEMORRHAGE MORTALITY
    7. PEPTIC ULCER DISEASE
    8. PREGNANCY AND IBD
    9. SECRETORY DIARRHOEA
    10. INVITED COMMENTARIES
    11. LETTERS TO THE EDITORS
    1. You have free access to this content
      Patients' knowledge of pregnancy-related issues in inflammatory bowel disease and validation of a novel assessment tool (‘CCPKnow’) (pages 57–63)

      C. P. Selinger, J. Eaden, W. Selby, D. B. Jones, P. Katelaris, G. Chapman, C. McDonald, J. McLaughlin, R. W. L. Leong and S. Lal

      Version of Record online: 9 MAY 2012 | DOI: 10.1111/j.1365-2036.2012.05130.x

  8. SECRETORY DIARRHOEA

    1. Top of page
    2. EDITORS' DECLARATIONS OF INTEREST
    3. REVIEW ARTICLE
    4. EPSTEIN-BARR HEPATITIS
    5. NON-ALCOHOLIC FATTY LIVER DISEASE
    6. UPPER GI HAEMORRHAGE MORTALITY
    7. PEPTIC ULCER DISEASE
    8. PREGNANCY AND IBD
    9. SECRETORY DIARRHOEA
    10. INVITED COMMENTARIES
    11. LETTERS TO THE EDITORS
    1. You have free access to this content
      The effects of loperamide, or loperamide plus simethicone, on the distribution of gut water as assessed by MRI in a mannitol model of secretory diarrhoea (pages 64–73)

      E. Placidi, L. Marciani, C. L. Hoad, A. Napolitano, K. C. Garsed, S. E. Pritchard, E. F. Cox, C. Costigan, R. C. Spiller and P. A. Gowland

      Version of Record online: 14 MAY 2012 | DOI: 10.1111/j.1365-2036.2012.05127.x

  9. INVITED COMMENTARIES

    1. Top of page
    2. EDITORS' DECLARATIONS OF INTEREST
    3. REVIEW ARTICLE
    4. EPSTEIN-BARR HEPATITIS
    5. NON-ALCOHOLIC FATTY LIVER DISEASE
    6. UPPER GI HAEMORRHAGE MORTALITY
    7. PEPTIC ULCER DISEASE
    8. PREGNANCY AND IBD
    9. SECRETORY DIARRHOEA
    10. INVITED COMMENTARIES
    11. LETTERS TO THE EDITORS
    1. You have free access to this content
    2. You have free access to this content
  10. LETTERS TO THE EDITORS

    1. Top of page
    2. EDITORS' DECLARATIONS OF INTEREST
    3. REVIEW ARTICLE
    4. EPSTEIN-BARR HEPATITIS
    5. NON-ALCOHOLIC FATTY LIVER DISEASE
    6. UPPER GI HAEMORRHAGE MORTALITY
    7. PEPTIC ULCER DISEASE
    8. PREGNANCY AND IBD
    9. SECRETORY DIARRHOEA
    10. INVITED COMMENTARIES
    11. LETTERS TO THE EDITORS
    1. You have free access to this content
      Letter: acute hepatitis B – to treat or not to treat? (pages 76–77)

      F. Casals-Seoane, B. Arberas-Diez and R. Moreno-Otero

      Version of Record online: 1 JUN 2012 | DOI: 10.1111/j.1365-2036.2012.05123.x

    2. You have free access to this content
      Letter: pathogenesis of tumour necrosis factor-alpha antagonists-induced psoriasiform lesions (pages 77–78)

      R. Denadai, F. V. Teixeira and R. Saad-Hossne

      Version of Record online: 1 JUN 2012 | DOI: 10.1111/j.1365-2036.2012.05126.x

SEARCH

SEARCH BY CITATION